cas 2215028-64-9|| where to buy 6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

Nombre del producto:6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

IUPAC Name:6-chloro-3-iodo-1-(oxan-2-yl)-1H-pyrazolo[3,4-b]pyrazine

Unidad de embalaje	Stock disponible	Precio($)
CM479274-1g	in stock	ȬƎũ
CM479274-5g	in stock	ǜưƀȺ
CM479274-10g	in stock	ưȺƦƎ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2215028-64-9; Fórmula molecular:C10H10ClIN4O; Punto de fusión:-; Código de sonrisas:ClC1=CN=C2C(I)=NN(C3CCCCO3)C2=N1; Densidad:

: Número de catálogo:CM479274; Peso molecular:364.57; Punto de ebullición:; Nº Mdl:MFCD32220431; Almacenamiento:

: Pyrazolopyrazines; The pyrazolopyrazine ring system is a very interesting class of heterocyclic compounds considered as important scaffolds for many effective bioactive agents with low toxicity, antioxidant, anticonvulsant, antiparasitic, anti-inflammatory, antiviral, antibacterial, anti- Fungal and analgesic activity.

: GDC-1971; Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.